Bausch Health Companies (BHC) Current Deferred Revenue (2009 - 2012)

Bausch Health Companies has disclosed Current Deferred Revenue across 4 years of filings, most recently posting $7.0 million for Q4 2012.

• Current Deferred Revenue for Q4 2012 came in at $7.0 million, down 44.99% year-over-year; the trailing twelve-month figure through Dec 2012 was $7.0 million (down 44.99% YoY), and the FY2012 annual result was $7.0 million, down 44.99% from the prior year.
• Current Deferred Revenue came in at $7.0 million for Q4 2012 at Bausch Health Companies, down from $18.1 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $23.3 million in Q3 2010 to a low of $7.0 million in Q2 2012.
• The 4-year median for Current Deferred Revenue is $18.6 million (2011), against an average of $16.5 million.
• Peak annual rise in Current Deferred Revenue reached 23.02% in 2012, while the deepest fall reached 63.12% in 2012.
• Bausch Health Companies' Current Deferred Revenue stood at $21.8 million in 2009, then fell by 1.44% to $21.5 million in 2010, then slumped by 40.6% to $12.8 million in 2011, then sank by 44.99% to $7.0 million in 2012.
• The last three Current Deferred Revenue figures came in at $7.0 million (Q4 2012), $18.1 million (Q3 2012), and $7.0 million (Q2 2012), per Business Quant data.